MURDOCK RICHARD D 4

4 · SANGSTAT MEDICAL CORP · Filed Sep 15, 2003

Insider Transaction Report

Form 4

Period: 2003-09-11

SANGSTAT MEDICAL CORPSANG

MURDOCK RICHARD D

DirectorChairman, President & CEO

Transactions

Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−1,034$23,265→ 0 total
Exercise/Conversion
Common Stock
2003-09-11$17.32/sh+48,454$839,223→ 48,454 total
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−5,000$112,500→ 0 total
Exercise/Conversion
Common Stock
2003-09-11$13.50/sh+9,000$121,500→ 9,000 total
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−9,000$202,500→ 0 total
Exercise/Conversion
Common Stock
2003-09-11$17.32/sh+11,546$199,977→ 11,546 total
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−48,454$1,090,215→ 0 total
Exercise: $17.32From: 2003-09-11Exp: 2012-10-22→ Common Stock (48,454 underlying)
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−1,879$42,278→ 0 total
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−8,000$180,000→ 0 total
Exercise: $12.99From: 2003-09-11Exp: 2011-06-13→ Common Stock (8,000 underlying)
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−45,044$1,013,490→ 0 total
Exercise: $8.88From: 2003-09-11Exp: 2013-03-27→ Common Stock (45,044 underlying)
Exercise/Conversion
Common Stock
2003-09-11$20.75/sh+4,000$83,000→ 4,000 total
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−11,546$259,785→ 0 total
Exercise: $17.32From: 2003-09-11Exp: 2012-10-22→ Common Stock (11,546 underlying)
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−1,879$42,278→ 0 total
Exercise: $11.94From: 2003-09-11Exp: 2011-01-02→ Common Stock (1,879 underlying)
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−4,000$90,000→ 0 total
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−8,000$180,000→ 0 total
Exercise/Conversion
Common Stock
2003-09-11$12.99/sh+8,000$103,920→ 8,000 total
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−11,546$259,785→ 0 total
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−45,044$1,013,490→ 0 total
Exercise/Conversion
Common Stock
2003-09-11$11.94/sh+1,879$22,431→ 1,879 total
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−10,000$225,000→ 0 total
Exercise/Conversion
Common Stock
2003-09-11$22.00/sh+1,034$22,748→ 1,034 total
Exercise/Conversion
Common Stock
2003-09-11$19.75/sh+10,000$197,500→ 10,000 total
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−254,956$5,736,510→ 0 total
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−9,000$202,500→ 0 total
Exercise: $13.50From: 2003-09-11Exp: 2006-07-24→ Common Stock (9,000 underlying)
Exercise/Conversion
Common Stock
2003-09-11$8.88/sh+45,044$399,991→ 45,044 total
Disposition to Issuer
Common Stock
2003-09-11$22.50/sh−48,454$1,090,215→ 0 total
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−254,956$5,736,510→ 0 total
Exercise: $8.88From: 2003-09-11Exp: 2013-03-27→ Common Stock (254,956 underlying)
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−10,000$225,000→ 0 total
Exercise: $19.75From: 2003-09-11Exp: 2008-10-07→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2003-09-11$8.88/sh+254,956$2,264,009→ 254,956 total
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−4,000$90,000→ 0 total
Exercise: $20.75From: 2003-09-11Exp: 2009-07-22→ Common Stock (4,000 underlying)
Exercise/Conversion
Option to purchase Common Stock
2003-09-11$22.50/sh−1,034$23,265→ 0 total
Exercise: $22.00From: 2003-09-11Exp: 2009-10-01→ Common Stock (1,034 underlying)

Footnotes (1)

[F1]Option vesting was accelerated and the underlying common stock and all other common stock owned by the reporting person was acquired by Genzyme Corporation ("Genzyme") pursuant to the Agreement and Plan of Merger by and among Genzyme, Swift Starboard Corporation and SangStat Medical Corporation.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION